Virtus Health
Fertility firm boss happy to ‘have the chat’ with potential suitors
Monash’s CEO said the company would be happy to talk to firms about a takeover but said the stability of ownership had been a plus for recruitment.
- Emma Koehn
Latest
- Opinion
- Mergers & acquisitions
Two predators, 8 bids and an IVF prize: Who will be left holding the $700m baby?
Five months ago IVF player Virtus Health was an unloved stock but now it’s become one of the most fiercely contested takeover battles in recent memory. The main reason - it’s cheap.
Fertility fight heats up as BGH makes cash offer for Virtus
Australian venture capital firm BGH has made the rare step of offering Virtus investors cash for their shares today in an off-market takeover bid.
- Emma Koehn
Virtus inks $706m deal with CapVest after lengthy takeover battle
The Australian IVF operator has sealed a takeover deal with UK-based private equity firm CapVest after a bidding war with local investor BGH Capital.
- Emma Koehn
Virtus 'leaned in' to COVID-19 crisis: CEO
The ASX-listed IVF operator has managed to eke out a profit for fiscal 2020 despite the COVID-19 pandemic putting the brakes on elective surgeries.
- Emma Koehn
IVF clinics look to remote consultations to bounce back from pandemic
Fertility treatments have been hit hard in the coronavirus crisis, but operators say they are finding a way through the patient backlog.
- Emma Koehn
The controversial fertility specialist putting the va-va-voom into IVF
Melbourne “baby whisperer” Lynn Burmeister has a pink-infused and hyper-femme game plan to shake up Australia’s $550 million IVF industry. But not everyone’s tickled pink.
- Melissa Fyfe
Original URL: https://www.smh.com.au/topic/vrt-1mm